INHSU 2019 welcomes submissions of abstracts for original contribution to the Conference.  Hepatitis care is herein inclusive of health care provided to people who use drugs at risk or infected by hepatitis C (or hepatitis), with the objective of enhancing global health and quality of life, and not exclusively Hepatitis prevention and treatment. As such, abstracts that focus on health issues among people who use drugs beyond hepatitis C are welcomed and encouraged.